[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853
Sort by:

Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021

US$ 3,500.00

Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Gamma Secretase - Drugs In Development, 2021'; Gamma Secretase (EC 3.4.23.) pipeline Targe...

August 2021 87 pages

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Drugs In Development, 2021

US$ 3,500.00

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Drugs In Development, 2021 SUMMARY Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) pipeline Target constitutes close to 8 mole...

August 2021 81 pages

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Drugs In Development, 2021

US$ 3,500.00

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Histone Deacetylase 1 - Drugs In Development, 2021'; Histone Deacetylase 1...

August 2021 191 pages

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Drugs In Development, 2021

US$ 3,500.00

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Drugs In Development, 2021 SUMMARY Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) pipeline Target constitutes close...

August 2021 124 pages

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Drugs In Development, 2021

US$ 3,500.00

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Drugs In Development, 2021 SUMMARY Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or H...

August 2021 154 pages

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Drugs In Development, 2021

US$ 3,500.00

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Drugs In Development, 2021 SUMMARY Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PG...

August 2021 113 pages

Retinoic Acid Receptor Alpha - Drugs In Development, 2021

US$ 3,500.00

Retinoic Acid Receptor Alpha - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) pipeline Target constitutes...

August 2021 76 pages

Retinoic Acid Receptor Gamma - Drugs In Development, 2021

US$ 3,500.00

Retinoic Acid Receptor Gamma - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Retinoic acid receptor ga...

August 2021 88 pages

Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adrenocortical Carc...

August 2021 416 pages

Allergic Conjunctivitis (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Allergic Conjunctivitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis - Drugs In Deve...

August 2021 132 pages

Asthma (Respiratory) - Drugs In Development, 2021

US$ 2,500.00

Asthma (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Drugs In Development, 2021, provides an overview...

August 2021 931 pages

Atherosclerosis (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Atherosclerosis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Drugs In Development, 2021,...

August 2021 276 pages

Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Basal Cell Carcinoma -...

August 2021 545 pages

Behcet Disease (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Behcet Disease (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Behcet Disease - Drugs In Development, 2021, pr...

August 2021 72 pages

Bone Metastasis (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Bone Metastasis (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bone Metastasis - Drugs In Development, 2021, provid...

August 2021 106 pages

Bronchiectasis (Respiratory) - Drugs In Development, 2021

US$ 2,000.00

Bronchiectasis (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2021, provi...

August 2021 123 pages

Cataract (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Cataract (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cataract - Drugs In Development, 2021, provides an ove...

August 2021 46 pages

Chikungunya Fever (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Chikungunya Fever (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chikungunya Fever - Drugs In Development...

August 2021 155 pages

Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021

US$ 2,500.00

Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive...

August 2021 675 pages

Corneal Neovascularization (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Corneal Neovascularization (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Corneal Neovascularization - Drugs I...

August 2021 47 pages

Critical Limb Ischemia (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Critical Limb Ischemia (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Critical Limb Ischemia - Drugs In Devel...

August 2021 163 pages

Essential Thrombocythemia (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Essential Thrombocythemia (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Essential Thrombocythemia - Drugs In Devel...

August 2021 137 pages

Fallopian Tube Cancer (Oncology) - Drugs In Development, 2021

US$ 2,500.00

Fallopian Tube Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fallopian Tube Cancer - Drugs In Development,...

August 2021 2046 pages

Gastric Cancer (Oncology) - Drugs In Development, 2021

US$ 2,500.00

Gastric Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Drugs In Development, 2021, provides...

August 2021 3373 pages

Hairy Cell Leukemia (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Hairy Cell Leukemia (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hairy Cell Leukemia - Drugs In Development, 2021...

August 2021 194 pages

Head And Neck Cancer (Oncology) - Drugs In Development, 2021

US$ 2,500.00

Head And Neck Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Drugs In Development, 20...

August 2021 4327 pages

Hepatitis A (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Hepatitis A (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Drugs In Development, 2021, prov...

August 2021 31 pages

Hypertrophic Cardiomyopathy (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Hypertrophic Cardiomyopathy (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy - Drug...

August 2021 116 pages

Idiopathic Pulmonary Fibrosis (Respiratory) - Drugs In Development, 2021

US$ 2,500.00

Idiopathic Pulmonary Fibrosis (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis - Dru...

August 2021 697 pages

Inclusion Body Myositis (IBM) (Metabolic Disorder) - Drugs In Development, 2021

US$ 2,000.00

Inclusion Body Myositis (IBM) (Metabolic Disorder) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Inclusion Body Myositis - Dr...

August 2021 61 pages

Keratitis (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Keratitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keratitis - Drugs In Development, 2021, provides an o...

August 2021 105 pages

Optic Neuritis (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Optic Neuritis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuritis - Drugs In Development, 2021, pro...

August 2021 57 pages

Organophosphate and Carbamate Poisoning (Other Diseases) - Drugs In Development, 2021

US$ 2,000.00

Organophosphate and Carbamate Poisoning (Other Diseases) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Organophosphate and Ca...

August 2021 37 pages

Oropharyngeal Cancer (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Oropharyngeal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Oropharyngeal Cancer - Drugs In Development, 20...

August 2021 978 pages

Osteoporosis (Musculoskeletal) - Drugs In Development, 2021

US$ 2,500.00

Osteoporosis (Musculoskeletal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Drugs In Development, 2021, provi...

August 2021 401 pages

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Peripheral Arterial Disease (PAD)/Peripheral Vascular Disease (PVD) (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...

August 2021 278 pages

Pheochromocytoma (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Pheochromocytoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pheochromocytoma - Drugs In Development, 2021, prov...

August 2021 179 pages

Pompe Disease (Musculoskeletal) - Drugs In Development, 2021

US$ 2,000.00

Pompe Disease (Musculoskeletal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pompe Disease - Drugs In Development, 2021, pro...

August 2021 121 pages

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021

US$ 2,000.00

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - D...

August 2021 137 pages

Rabies (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Rabies (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rabies - Drugs In Development, 2021, provides an ov...

August 2021 108 pages

Retinoblastoma (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Retinoblastoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinoblastoma - Drugs In Development, 2021, provides...

August 2021 84 pages

Rotavirus Infections (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Rotavirus Infections (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rotavirus Infections - Drugs In Devel...

August 2021 65 pages

Stroke (Cardiovascular) - Drugs In Development, 2021

US$ 2,500.00

Stroke (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Drugs In Development, 2021, provides an overvi...

August 2021 862 pages

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) (Hematology) - Drugs In Development, 2021

US$ 2,000.00

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) (Hematology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thrombot...

August 2021 52 pages

Ureter Cancer (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Ureter Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ureter Cancer - Drugs In Development, 2021, provides a...

August 2021 516 pages

Ventricular Tachycardia (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Ventricular Tachycardia (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ventricular Tachycardia - Drugs In Dev...

August 2021 56 pages

5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021

US$ 3,500.00

5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021'; 5-Hydroxytryptamine Recept...

July 2021 63 pages

Achondroplasia (Musculoskeletal) - Drugs In Development, 2021

US$ 2,000.00

Achondroplasia (Musculoskeletal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Drugs In Development, 2021, p...

July 2021 83 pages

Acid Sphingomyelinase Deficiency Type C (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Acid Sphingomyelinase Deficiency Type C (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acid Sphingom...

July 2021 139 pages

Acinetobacter Infections (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Acinetobacter Infections (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acinetobacter Infections - Drugs...

July 2021 229 pages

Filters

Search

Categories

2,264
2,910
126
9
6
1
1
1
4
522
3
6

Publishers

5,853

Regions

5,853

Price

Date

Pages

Offers